• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质、胰腺星状细胞与胰腺肿瘤发展之间的动态相互作用:新的治疗靶点。

The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets.

机构信息

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, 30322, USA.

出版信息

Cytokine Growth Factor Rev. 2019 Aug;48:11-23. doi: 10.1016/j.cytogfr.2019.07.001. Epub 2019 Jul 17.

DOI:10.1016/j.cytogfr.2019.07.001
PMID:31331827
Abstract

The stroma is a main driver of metastasis and aggressiveness in pancreatic cancer (PC), one of the deadliest malignancies worldwide. Pancreatic stellate cells (PSCs) form approximately 50% of the pancreatic tumor stroma, causing desmoplasia, extracellular matrix (ECM) deposition, epithelial-to-mesenchymal transition (EMT) and metastatic spread. Furthermore, activated PSCs can remodel the pancreatic tumor microenvironment (TME) via dynamic and complex interactions and feedback loops with PC cells, thus facilitating tumor growth through various signalling and immune pathways. Hence, increased understanding of these cellular cross-talks and how they shape the TME in PC might guide the development of novel treatment approaches against this stubborn and deadly malignancy that has so far resisted therapeutic advances. In this review, we will explore the role of the stroma and PSCs in PC development, invasion and metastasis, examine their interaction with PC cells and discuss potential treatment approaches aimed at targeting PSCs in order to reprogram the pancreatic tumor environment.

摘要

基质是胰腺癌(PC)转移和侵袭性的主要驱动因素,PC 是全球最致命的恶性肿瘤之一。胰腺星状细胞(PSC)约占胰腺肿瘤基质的 50%,导致了纤维组织增生、细胞外基质(ECM)沉积、上皮间质转化(EMT)和转移扩散。此外,激活的 PSCs 可以通过与 PC 细胞的动态和复杂相互作用及反馈环重塑胰腺肿瘤微环境(TME),从而通过各种信号和免疫途径促进肿瘤生长。因此,增加对这些细胞串扰的理解以及它们如何塑造 PC 中的 TME,可能有助于指导针对这种顽固且致命的恶性肿瘤的新治疗方法的开发,迄今为止,这种恶性肿瘤一直抵制治疗进展。在这篇综述中,我们将探讨基质和 PSCs 在 PC 发展、侵袭和转移中的作用,研究它们与 PC 细胞的相互作用,并讨论旨在靶向 PSCs 以重新编程胰腺肿瘤环境的潜在治疗方法。

相似文献

1
The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets.基质、胰腺星状细胞与胰腺肿瘤发展之间的动态相互作用:新的治疗靶点。
Cytokine Growth Factor Rev. 2019 Aug;48:11-23. doi: 10.1016/j.cytogfr.2019.07.001. Epub 2019 Jul 17.
2
Suppression of CD51 in pancreatic stellate cells inhibits tumor growth by reducing stroma and altering tumor-stromal interaction in pancreatic cancer.抑制胰腺星状细胞中的CD51可通过减少基质和改变胰腺癌中的肿瘤-基质相互作用来抑制肿瘤生长。
Int J Oncol. 2016 Apr;48(4):1499-508. doi: 10.3892/ijo.2016.3374. Epub 2016 Feb 3.
3
Pancreatic Tumor Microenvironment.胰腺肿瘤微环境。
Adv Exp Med Biol. 2020;1296:243-257. doi: 10.1007/978-3-030-59038-3_15.
4
Pancreatic Stellate Cells: The Key Orchestrator of The Pancreatic Tumor Microenvironment.胰腺星状细胞:胰腺肿瘤微环境的关键协调者。
Adv Exp Med Biol. 2020;1234:57-70. doi: 10.1007/978-3-030-37184-5_5.
5
Microfluidic co-culture of pancreatic tumor spheroids with stellate cells as a novel 3D model for investigation of stroma-mediated cell motility and drug resistance.微流控共培养胰腺肿瘤球体与星状细胞作为一种新型的 3D 模型用于研究基质介导的细胞迁移和耐药性。
J Exp Clin Cancer Res. 2018 Jan 12;37(1):4. doi: 10.1186/s13046-017-0654-6.
6
Pancreatic stellate cell: Pandora's box for pancreatic disease biology.胰腺星状细胞:胰腺疾病生物学的潘多拉魔盒。
World J Gastroenterol. 2017 Jan 21;23(3):382-405. doi: 10.3748/wjg.v23.i3.382.
7
Pancreatic cancer stroma: controversies and current insights.胰腺癌基质:争议与当前见解
Scand J Gastroenterol. 2017 Jun-Jul;52(6-7):641-646. doi: 10.1080/00365521.2017.1293726. Epub 2017 Feb 24.
8
Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms.阿朴脂蛋白通过自分泌和旁分泌机制调节上皮-间质转化(EMT),从而促进胰腺癌细胞的侵袭和迁移。
Cancer Lett. 2017 Jul 10;398:24-36. doi: 10.1016/j.canlet.2017.04.001. Epub 2017 Apr 9.
9
Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility.胰腺癌基质缺氧星状细胞调节细胞外基质纤维组织和癌细胞迁移。
Cancer Lett. 2016 Mar 28;372(2):210-8. doi: 10.1016/j.canlet.2016.01.016. Epub 2016 Jan 19.
10
Pancreatic stellate cells: A dynamic player of the intercellular communication in pancreatic cancer.胰腺星状细胞:胰腺癌细胞间通讯的活跃参与者。
Clin Res Hepatol Gastroenterol. 2015 Sep;39 Suppl 1:S98-103. doi: 10.1016/j.clinre.2015.05.018. Epub 2015 Jul 16.

引用本文的文献

1
Quantitative characterization of the 3D self-organization of PDAC tumor spheroids reveals cell type and matrix dependence through advanced microscopy analysis.通过先进的显微镜分析对胰腺导管腺癌(PDAC)肿瘤球体的三维自组织进行定量表征,揭示了细胞类型和基质依赖性。
APL Bioeng. 2025 Mar 27;9(1):016116. doi: 10.1063/5.0242490. eCollection 2025 Mar.
2
Cross-Talk Between Cancer and Its Cellular Environment-A Role in Cancer Progression.癌症与其细胞微环境之间的相互作用——在癌症进展中的作用
Cells. 2025 Mar 10;14(6):403. doi: 10.3390/cells14060403.
3
Facilitation of Tumor Stroma-Targeted Therapy: Model Difficulty and Co-Culture Organoid Method.
促进肿瘤基质靶向治疗:模型难点与共培养类器官方法
Pharmaceuticals (Basel). 2025 Jan 8;18(1):62. doi: 10.3390/ph18010062.
4
Informatics strategies for early detection and risk mitigation in pancreatic cancer patients.胰腺癌患者早期检测和风险缓解的信息学策略。
Neoplasia. 2025 Feb;60:101129. doi: 10.1016/j.neo.2025.101129. Epub 2025 Jan 21.
5
Pancreatic stellate cells support human pancreatic β-cell viability and enhance survival of immunoisolated human islets exposed to cytokines.胰腺星状细胞维持人胰腺β细胞的活力,并提高暴露于细胞因子的免疫隔离人胰岛的存活率。
Mater Today Bio. 2024 Jun 18;27:101129. doi: 10.1016/j.mtbio.2024.101129. eCollection 2024 Aug.
6
The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers.胰腺癌前病变中宏观和微观环境之间的串扰导致了新的、有前途的循环生物标志物。
J Exp Clin Cancer Res. 2024 Jul 18;43(1):198. doi: 10.1186/s13046-024-03117-5.
7
New avenues for the treatment of immunotherapy-resistant pancreatic cancer.治疗免疫疗法耐药性胰腺癌的新途径。
World J Gastrointest Oncol. 2024 Apr 15;16(4):1134-1153. doi: 10.4251/wjgo.v16.i4.1134.
8
Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy.胰腺癌中的胰腺星状细胞:作为未来治疗的潜在靶点
Front Oncol. 2023 Jun 20;13:1185093. doi: 10.3389/fonc.2023.1185093. eCollection 2023.
9
Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective.针对胰腺癌免疫治疗的肿瘤免疫抑制微环境:当前研究与未来展望
Front Oncol. 2023 Mar 29;13:1166860. doi: 10.3389/fonc.2023.1166860. eCollection 2023.
10
The synthesis of a nanodrug using metal-based nanozymes conjugated with ginsenoside Rg3 for pancreatic cancer therapy.一种使用与人参皂苷Rg3偶联的金属基纳米酶合成用于胰腺癌治疗的纳米药物。
Nanoscale Adv. 2021 Nov 17;4(1):190-199. doi: 10.1039/d1na00697e. eCollection 2021 Dec 21.